期刊文献+

心血管磁共振成像钆剂延迟增强在心肌病变中的应用 被引量:2

Evaluation of cardiomyopathy by late gadolinium-enhanced cardiovascular magnetic resonance imaging
下载PDF
导出
摘要 目的评估钆剂延迟增强(LGE)对心肌病变的诊断价值。方法收集2010-01—2013-01具有完整心血管磁共振(CMR)图像病例51例,其中男32例。女19例,年龄17-79(49.8±16.0)岁。由2位影像诊断医师独立盲法评估CMR图像中LGE有无、LGE部位(心内膜下、透壁、壁间、心外膜下)及形态(斑点/斑片样、线条样、片状/片状),并行Kappa一致性检验,同时评价LGE与心肌病变的关系。结果临床确诊有心肌病变39例,2位影像诊断医师对LGE征象有无、部位、形态的判定一致性较好(Kappa=0.876、0.678、0.686,均P<0.01或0.05)。CMR-LGE可以显示心肌病变(X^2=13.226,P<0.05).其敏感度、特异度、阳性预测值、阴性预测值分别为79.5%、83.3%、93.9%、55.6%。其中缺血性心肌病LGE主要为心内膜下或透壁型,占81.8%(9/11),以片状强化多见72.7%(8/11)。炎性心肌病变主要位于心肌壁间75.0%(6/8)。强化形态多样,斑点/斑片样、线条样、片状均可见。而非缺血性心肌病中。LGE征象可出现于心内膜下、透壁、壁间,形态以斑点、斑片样多见。结论 LGE是CMR检查的一个重要组成部分。可以检测心肌病变的有无及范围,有助于临床医师识别与心脏有关的症状和病因。 Objective To evaluate the application of late gadolinium-enhanced cardiovascular magnetic resonance (LGE-CMR) images in diagnosis of myocardiepathy. Methods Fifty one patients, including 32 males and 19 females aged 17-79y received LGE-CMR examination during January 2010 and January 2013. The LGE-CMR images were evaluated by two radiologists independentLy, in terms of LGE Locations (subendocardial, transmural, mid-wall, subepicardial) and LGE patterns (spot/spots, linear, patchy). Kappa test for consistency and x" for the relationship between LGE and cardiomyopathy were per- formed. Results Myocardial lesions were found in 39 cases by clinical follow-up or pathology. There was a good consistency in diagnosis, LGE location and pattern between 2 radiologists (Kappa= 0.876, 0.678, 0.686, P〈0.05 or 0.01). LGE-CMR well demonstrated myocardial lesions (x-~= 13.226, P〈0.05) with a sensitivity, specificity, positive predictive value and negative predic- tive value of 79.5%, 83.3%, 93.9% and 55.6%, respectively. The LGE in ischemic cardiomyopathy was mostly located in suben- docardial or transmural (81.8%) sites, and patchy enhancement was common (72.7%).The LGE in inflammatory cardiomyopathy was mainly situated in mid-wall (75.0%), and spot/spots (3/8), linear (3/8), patchy (2/8) enhancements were all visible. In the non-ischemic cardiomyopathy, LGE signs were in subendocardial, transmural or mid-wall sites, and inclined to be spot/spots-like enhancement. Conclusion LGE-CMR is helpful in evaluation of cardiac lesions and its features in patients with cardiomyopathy.
出处 《浙江医学》 CAS 2014年第6期463-466,478,共5页 Zhejiang Medical Journal
基金 863计划项目(2012AA02A602)
关键词 心血管磁共振钆剂延迟增强心肌病变 Cardiac magnetic resonance Late gadolinium enhancement Myocardial lesions
  • 相关文献

参考文献25

  • 1Bandettini W P, Kellman P, Mancini C, et a!. MultiContrast DelayedEnhancement (MCODE) improves detection of subendocardialmyocardial infarction by late gadolinium enhancement cardiovas-cular magnetic resonance: a clinical validation study [J],Cardio-vasc Magn Reson,2012, 30(14):83. 被引量:1
  • 2Wang L, Yan C, Zhao S, et al. Comparison of (99m)Tc-M旧I SPECT/18F-FDG PET imaging and cardiac magnetic resonance imagingin patients with idiopathic dilated cardiomyopathy: assessment ofcardiac function and myocardial injury[J], Clin Nucl Med, 2012, 37(12):1163-1169. 被引量:1
  • 3Aldrovandi A, De Ridder S P, Strohm o,et al. Detection of papil-lary muscle infarction by late gadolinium enhancement: incre-mental value of short-inversion time vs. standard imaging[J]. EurHeart J Cardiovasc Imaging, 2013, 14(5):495-499. 被引量:1
  • 4Song B G, Yang H S, Hwang H K, et al. Correlation of electrocar-diographic changes and myocardial fibrosis in patients with hy-pertrophic cardiomyopathy detected by cardiac magnetic reso-nance imaging[J]. Clin Cardiol, 2013, 36(1):31-35. 被引量:1
  • 5Naruse Y, Sato A, Kasahara K, et al. The clinical impact of lategadolinium enhancement in Takotsubo cardiomyopathy: serialanalysis of cardiovascular magnetic resonance images [J]. Car-diovasc Magn Reson, 2011, 13:67. 被引量:1
  • 6Pereira R S, Prato F S, Wisenberg G, et al. The determination ofmyocardial viability using Gd-DTPA in a canine model of acutemyocardial ischemia and reperfusion[J]. Magn Reson Med ,1996,36(5):684-693. 被引量:1
  • 7Rehwald W G, Fieno D S, Chen E L, et al. Myocardial magneticresonance imaging contrast agent concentrations after reversibleand irreversible ischemic injury [J], Circulation, 2002,105:224-229. 被引量:1
  • 8Pereira R S, Prato F S, Sykes J, et al. Assessment of myocardialviability using MRl during a constant infusion of Gd-DTPA: furtherstudies at early and late periods of reperfusion[J]. Magn ResonMed,1999,42(1):60-68. 被引量:1
  • 9Kim R J, Judd R M, Chen E L, et a丨.Relationship of elevated 23Namagnetic resonance image intensity to infarct size after acutereperfused myocardial infarction[J]. Circulation^ 999,100:185-192. 被引量:1
  • 10Mahrholdt H, Wagner A, Judd R M, et al. Delayed enhancementcardiovascular magnetic resonance assessment of non-is-chaemic cardiomyopathies[J], Eur Heart J,2005, 26:1461-1474. 被引量:1

二级参考文献20

  • 1朱海云,田建明,王莉,曾浩,黄胜东,徐训宇.磁共振多技术联合应用检测存活心肌的实验研究[J].临床放射学杂志,2005,24(3):264-269. 被引量:9
  • 2时惠平,高育璈,高元桂.磁共振成像对急性心肌梗死后再灌注损伤和左室重构的评估(英文)[J].中国临床康复,2005,9(27):208-209. 被引量:2
  • 3赵世华,闫朝武,杨敏福,陆敏杰,蒋世良,李世国,张岩,刘琼,刘玉清,何作祥.磁共振心肌灌注延迟增强与核素心肌灌注/代谢显像识别存活心肌对比研究[J].中华心血管病杂志,2006,34(12):1072-1076. 被引量:26
  • 4Muellerleile K, Barmeyer A, Groth M, et al. Assessment of myocardial Viability in ischemic heart disease by cardiac magnetic resonance imaging [ J ]. Minerva Cardioangio1,2008,56 ( 2 ) :237-249. 被引量:1
  • 5Weinsaft JW,Klem I,Judd RM. MRI for the assessment of myocardial viability [ J ]. Cardiol Clin, 2007,25 ( 1 ) : 35-56. 被引量:1
  • 6Koszegi Z, Caluska L, Szakall SJ r, et al. The role of PET scan among cardiologic imagingmethods [ J ]. Orv Hetil, 2002,143 ( 12 Suppl 3 ) : 1314-1316. 被引量:1
  • 7Laissy JP, Hyafil F, Feldman LJ, et al. Differentiating acute myocardial infarction from myocarditis:diagnostic value of early and delayed perfusion cardiac MR imaging[ J]. Radiology,2005,237( 1 ):75-82. 被引量:1
  • 8Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomy yopathy using delayed-enhancement magnetic resonance imaging[J]. J Am CollCardiol,2005,45:98-103. 被引量:1
  • 9Wu YW, Huang PJ, Lee CM, et al. Assessment of myocardial viability using F-18 fluorodeoxyglucose/Tc-99m sestamibi dual-isotope simultaneous acquisition SPECT:eomparison with T1-201 stress-reinjection SPECT [ J 1. J Nucl Cardiol,2005,12 ( 4 ) :451-459. 被引量:1
  • 10Kuhl HP, Beek AM, Van derWeerdtAP, et al. Myocardial viability in chronic ischemic heart disease:comparison of contrast enhanced magnetic resonance imageing with(18) F-fluorodeoxyglucose positron emission tomography[ J]. J AM Cool Cardiol,2003 ,41:1341-1348. 被引量:1

共引文献8

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部